These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23350193)

  • 21. Wide excision of soft tissues adjacent to the ovary and fallopian tube does not impair the ovarian reserve in women undergoing prophylactic bilateral salpingectomy: results from a randomized, controlled trial.
    Venturella R; Morelli M; Lico D; Di Cello A; Rocca M; Sacchinelli A; Mocciaro R; D'Alessandro P; Maiorana A; Gizzo S; Zullo F
    Fertil Steril; 2015 Nov; 104(5):1332-9. PubMed ID: 26335129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two unusual uses of steroid hoones in pelvic infections.
    Campbell C
    Clin Obstet Gynecol; 1969 Mar; 12(1):247-51. PubMed ID: 5797136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.
    Sahmay S; Guralp O; Aydogan B; Cepni I; Oral E; Irez T
    Gynecol Endocrinol; 2013 May; 29(5):440-3. PubMed ID: 23461296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum level of anti-mullerian hormone in early follicular phase as a predictor of ovarian reserve and pregnancy outcome in assisted reproductive technology cycles.
    Dehghani-Firouzabadi R; Tayebi N; Asgharnia M
    Arch Iran Med; 2008 Jul; 11(4):371-6. PubMed ID: 18588367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of isotretinoin on ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with acne.
    Aksoy H; Cinar L; Acmaz G; Aksoy U; Aydin T; Vurdem UE; Oz L; Idem Karadag O; Kartal D
    Gynecol Obstet Invest; 2015; 79(2):78-82. PubMed ID: 25660129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.
    Janse F; Donnez J; Anckaert E; de Jong FH; Fauser BC; Dolmans MM
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1136-44. PubMed ID: 21289248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti mullerian hormone (AMH)--is it a new reliable marker of the ovarian reserve? Its role in predicting the ovarian response in assisted reproductive technology (ART)].
    Alshiek JA; Lessing JB; Amit A; Azem F
    Harefuah; 2012 Jul; 151(7):416-20, 435. PubMed ID: 23002694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study.
    Ganidou MA; Kolibianakis EM; Venetis CA; Gerou S; Makedos GA; Klearchou N; Tarlatzis BC
    Gynecol Endocrinol; 2014 Nov; 30(11):817-21. PubMed ID: 24989633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ovarian function in 35-40-year-old women with polycystic ovary syndrome.
    de Guevara AL; Crisosto N; Echiburú B; Preisler J; Vantman N; Bollmann J; Pérez-Bravo F; Sir-Petermann T
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):165-70. PubMed ID: 23845170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve.
    Uncu G; Kasapoglu I; Ozerkan K; Seyhan A; Oral Yilmaztepe A; Ata B
    Hum Reprod; 2013 Aug; 28(8):2140-5. PubMed ID: 23624580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
    Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
    Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
    Christiansen SC; Eilertsen TB; Vanky E; Carlsen SM
    PLoS One; 2016; 11(1):e0146739. PubMed ID: 26799212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoandrogenism in association with diminished functional ovarian reserve.
    Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
    Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Müllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation.
    Fabbri R; Macciocca M; Melotti C; Pasquinelli G; Vicenti R; Bacchi Reggiani ML; Terribile D; Venturoli S
    Future Oncol; 2014 Jun; 10(8):1343-51. PubMed ID: 25052745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and microbiological study of acute pelvic inflammatory disease].
    Ovalle A; Martínez MA; Casals A; Yuhaniak R; Giglio MS
    Rev Chil Obstet Ginecol; 1993; 58(2):103-12. PubMed ID: 8209036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone.
    Gleicher N; Weghofer A; Barad DH
    Fertil Steril; 2009 May; 91(5):1700-6. PubMed ID: 18384775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries.
    Kallio S; Aittomäki K; Piltonen T; Veijola R; Liakka A; Vaskivuo TE; Dunkel L; Tapanainen JS
    Hum Reprod; 2012 Mar; 27(3):854-60. PubMed ID: 22258659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade.
    Sørbye IK; Jerve F; Staff AC
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):290-6. PubMed ID: 15715539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.